Secnidazole for use in the treatment of bacterial vaginosis
AssigneeLupin Limited
InventorsHelen S. Pentikis, David Palling, Carol J. Braun
Life of this patent
Estimating the term…
Abstract
Embodiments are directed to a secnidazole formulations and the use of a secnidazole formulation for the treatment of bacterial vaginosis (BV).
Claims20
An oral pharmaceutical composition comprising a plurality of microgranules wherein the plurality of microgranules comprises a therapeutically effective amount of secnidazole, each microgranule comprises a sugar sphere core and an outer layer disposed on the sugar sphere core, the outer layer comprises secnidazole, wherein the therapeutically effective amount of secnidazole in the oral pharmaceutical composition is about 42% w/w based on the total weight of the oral pharmaceutical composition, wherein each microgranule has a particle diameter in the range of 400 micrometers to 841 micrometers, wherein the therapeutically effective amount of secnidazole in the composition is 2 grams and the secnidazole is the sole drug in the oral pharmaceutical composition.
Dependencies are inferred from the claim text.